The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
MRI identified missed cervical spine injuries in 17% of patients with trauma who had negative CT results, prompting treatment changes in 4% of them. MRI identified missed injuries in 17% of patients ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. A patient enters the MRI scanner for a full-body imaging session — ...
Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...
Bayer today announced that the U.S. Food and Drug Administration (FDA) approved AMBELVIST ® (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for ...
The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results